News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Nomura Lifts CSPC PHARMA (01093.HK) TP to $12.04, Keeps Buy Rating
Nomura issued a research report expecting that CSPC PHARMA (01093.HK)'s 4Q25 revenue will grow by 20% YoY to RMB7.6 billion, slightly higher than the market consensus of RMB7.4...
Reset
Send
The window will close in 5 seconds
<Research>Nomura Lifts CSPC PHARMA (01093.HK) TP to $12.04, Keeps Buy Rating
Close
Recommend
5
Positive
10
Negative
4
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Nomura issued a research report expecting that CSPC PHARMA (01093.HK)  +0.090 (+0.936%)    Short selling $314.42M; Ratio 92.374%   's 4Q25 revenue will grow by 20% YoY to RMB7.6 billion, slightly higher than the market consensus of RMB7.4 billion. The broker also anticipated that the sales of finished drugs will ebb by 1% YoY to RMB5 billion, while collaboration revenue will be RMB1.1 billion.

Furthermore, Nomura estimated the Group's gross profit margin to hike by 0.3 ppts YoY to 68.5%, with an operating profit margin of 19% and a net profit of RMB1.3 billion.

Considering the increase in CSPC PHARMA's collaboration revenue and the corresponding higher profit margin, the broker raised its FY2025/ 2026 revenue forecasts for the Company by 1%/ 7.2%, and elevated its earnings forecasts by 5.9%/ 26.4%.

Therefore, the broker kept rating at Buy for the Company, and lifted its target price from $9.11 to $12.04.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.